Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 206 entries
View as:

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT00447811 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01101100 Org: User:
Start: 04/30/10 End: 09/30/15 Due: 09/30/16

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Phase: N/A Priority: Normal
NCT ID: NCT00401362 Org: User:
Start: 02/28/03 End: 02/28/05 Due: 02/28/06

A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01149811 Org: User:
Start: 07/31/10 End: 11/30/10 Due: 11/30/11

Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00767728 Org: User:
Start: 12/31/04 End: 10/31/07 Due: 10/31/08

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

Phase: N/A Priority: Normal
NCT ID: NCT03168334 Org: User:
Start: 07/11/17 End: 07/24/18 Due: 07/24/19

Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

Phase: N/A Priority: Normal
NCT ID: NCT00045799 Org: User:
Start: 05/31/02 End: 05/31/03 Due: 05/31/04

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00858754 Org: User:
Start: 03/31/09 End: 08/31/09 Due: 08/31/10

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02240121 Org: User:
Start: 08/21/14 End: 08/16/17 Due: 08/16/18

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

Phase: N/A Priority: Normal
NCT ID: NCT04892706 Org: User:
Start: 06/11/21 End: 09/28/22 Due: 09/28/23

The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis

Phase: N/A Priority: Normal
NCT ID: NCT01349673 Org: User:
Start: 05/31/11 End: 12/31/14 Due: 12/31/15

Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00311350 Org: User:
Start: 03/31/06 End: 08/31/06 Due: 08/31/07

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

Phase: N/A Priority: Normal
NCT ID: NCT03168321 Org: User:
Start: 06/29/17 End: 06/07/18 Due: 06/07/19

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03988439 Org: User:
Start: 03/24/21 End: 06/30/24 Due: 06/30/25

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00162734 Org: User:
Start: 02/28/05 End: 06/30/07 Due: 06/30/08

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00804141 Org: User:
Start: 12/03/08 End: 09/20/10 Due: 09/20/11

SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01053962 Org: User:
Start: 03/31/10 End: 08/31/10 Due: 08/31/11

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02849860 Org: User:
Start: 02/28/14 End: 10/31/16 Due: 10/31/17

DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT00444353 Org: User:
Start: 08/31/04 End: 01/31/07 Due: 01/31/08

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00505583 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT01177410 Org: User:
Start: 07/31/10 End: 08/31/11 Due: 08/31/12

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

Phase: N/A Priority: Normal
NCT ID: NCT01366378 Org: User:
Start: 01/31/07 End: 02/28/07 Due: 02/28/08

Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05027282 Org: User:
Start: 10/27/21 End: 11/18/22 Due: 11/18/23

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01937260 Org: User:
Start: 09/30/13 End: 12/31/14 Due: 12/31/15

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Phase: N/A Priority: Normal
NCT ID: NCT00568997 Org: User:
Start: 06/27/05 End: 12/31/26 Due: 12/31/27